The Expression of CD14+CD16+Monocyte Subpopulation in Coronary Heart Disease Patients with Blood Stasis Syndrome
Authors:
Open Access
- 27 June 2013
- journal article
- research article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-6
Abstract
Blood stasis syndrome (BSS), a comprehensive pathological state, is one of the traditional Chinese medicine syndromes of coronary heart disease (CHD). In our previous study, we investigated that FcγRIIIA (also called CD14+CD16+monocyte subpopulation) is one of the differentially expressed genes related to CHD patients and its possible role in the atherosclerotic formation and plaque rupture. However, whether or not the deregulation of CD14+CD16+monocyte subpopulation expression is implicated in the pathogenesis of CHD patients with BSS has not yet been elucidated. In this study, we found that there was no significant difference between CHD patients with BSS and non-BSS in CD14+CD16+monocyte subpopulation at gene level. Moreover, the protein level of CD14+CD16+monocyte subpopulation in CHD patients with BSS was increased significantly when compared to the CHD patients with non-BSS. Additionally, the level of inflammatory cytokines downstream of CD14+CD16+monocyte subpopulation such as TNF-αand IL-1 in sera was much higher in CHD patients with BSS than that in CHD patients with non-BSS. Taken together, these results indicated that CD14+CD16+monocyte subpopulation was implicated in the pathogenesis of CHD patients with BSS, which may be one of the bases of the essence of BSS investigation.Keywords
Funding Information
- National Basic Research Program of China (81073086, 90409021)
This publication has 21 references indexed in Scilit:
- Chinese Herb and Formulas for Promoting Blood Circulation and Removing Blood Stasis and Antiplatelet TherapiesEvidence-Based Complementary and Alternative Medicine, 2012
- Monocytes in atherosclerosis: subsets and functionsNature Reviews Cardiology, 2010
- The formation of monocyte–platelet aggregates is independent of on-treatment residual agonists’-inducible platelet reactivityAtherosclerosis, 2009
- Differential gene expression profiles in coronary heart disease patients of blood stasis syndrome in traditional Chinese medicine and clinical role of target geneChinese Journal of Integrative Medicine, 2009
- The monocyte/macrophage as a therapeutic target in atherosclerosisCurrent Opinion in Pharmacology, 2009
- LPS-Induced Release of IL-1 β , IL-1Ra, IL-6, and TNF- α in Whole Blood from Patients with Familial Hypercholesterolemia: No Effect of Cholesterol-Lowering TreatmentJournal of Interferon & Cytokine Research, 2006
- Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout miceCardiovascular Research, 2005
- Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- A Novel Method to Compensate for Different Amplification Efficiencies between Patient DNA Samples in Quantitative Real-Time PCRThe Journal of Molecular Diagnostics, 2001
- Detection and localization of tumor necrosis factor in human atheromaThe American Journal of Cardiology, 1990